Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Sjogren’s syndrome
How long are cholinergic agonists such as pilocarpine required to be held before doing tear assessments (ocular scoring and Schirmer’s) and sialography/salivary collection?
Related Questions
What is your treatment approach to neurological Sjogrens disease with both peripheral neuropathy and transverse myelitis?
How would you treat chorea in a patient with Sjögren’s syndrome and positive beta 2 glycoprotein I antibodies?
How do you approach management of a patient with Sjogren's disease and lung mass biopsy revealing amyloidosis?
Would you modify your treatment approach for treating an HPV-positive head and neck cancer in a patient with symptomatic Sjogren's?
How do you approach hypocomplementemia in Sjogren’s without features of lymphoma?
How do you approach work up for underlying rheumatologic disease in patients referred for chronic urticaria?
What is your initial treatment paradigm for someone with both CNS and peripheral neurologic Sjogren’s?
Is monitoring for fetal heart block recommended in pregnant patients with only slightly elevated SSA?
Would you use a reduced dose glucocorticoid tapering regimen for patients with vasculitis due to Sjögren’s syndrome treated with Rituximab?
In patients with sicca symptoms and positive SSA/SSB how often do you perform other diagnostic testing such as salivary gland ultrasound, biopsy, Shirmers, ocular staining, stimulated salivary flow, etc?